Soleno Therapeutics Inc. buy Wells Fargo & Company
Start price
20.08.25
/
50%
€57.65
Target price
20.08.26
€105.76
Performance (%)
-21.94%
Price
27.04.26
€44.38
Summary
This prediction is currently active. The price of Soleno Therapeutics Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -21.94%. This prediction currently runs until 20.08.26. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Soleno Therapeutics Inc. | -0.314% | -0.314% |
| iShares Core DAX® | -1.424% | 8.918% |
| iShares Nasdaq 100 | 3.274% | 16.275% |
| iShares Nikkei 225® | 1.745% | 16.239% |
| iShares S&P 500 | 1.447% | 10.913% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Soleno Therapeutics Inc. diskutieren
Soleno Therapeutics (NASDAQ:SLNO) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $123.00 price target on the stock.
Ratings data for SLNO provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for Soleno Therapeutics Inc.
Soleno Therapeutics Inc.
Start price
Target price
Perf. (%)
€32.80
27.02.26
27.02.26
€93.24
27.02.27
27.02.27
37.20%
27.04.26
27.04.26
